Exagen Inc.
XGN
$6.43
-$0.45-6.54%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 55.64M | 55.75M | 56.66M | 55.73M | 52.55M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 55.64M | 55.75M | 56.66M | 55.73M | 52.55M |
Cost of Revenue | 22.53M | 22.97M | 23.16M | 22.98M | 23.09M |
Gross Profit | 33.11M | 32.78M | 33.51M | 32.75M | 29.46M |
SG&A Expenses | 41.37M | 43.39M | 44.60M | 46.09M | 47.43M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 69.28M | 71.15M | 72.47M | 73.87M | 75.39M |
Operating Income | -13.64M | -15.40M | -15.81M | -18.13M | -22.84M |
Income Before Tax | -15.10M | -16.89M | -17.28M | -19.33M | -23.66M |
Income Tax Expenses | 12.00K | 33.00K | 33.00K | 33.00K | 33.00K |
Earnings from Continuing Operations | -15.12 | -16.93 | -17.31 | -19.36 | -23.69 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -15.12M | -16.93M | -17.31M | -19.36M | -23.69M |
EBIT | -13.64M | -15.40M | -15.81M | -18.13M | -22.84M |
EBITDA | -11.91M | -13.58M | -13.81M | -16.06M | -20.67M |
EPS Basic | -0.83 | -0.94 | -0.97 | -1.09 | -1.34 |
Normalized Basic EPS | -0.52 | -0.59 | -0.60 | -0.68 | -0.84 |
EPS Diluted | -0.83 | -0.94 | -0.97 | -1.09 | -1.34 |
Normalized Diluted EPS | -0.52 | -0.59 | -0.60 | -0.68 | -0.84 |
Average Basic Shares Outstanding | 72.81M | 72.21M | 71.65M | 71.13M | 70.71M |
Average Diluted Shares Outstanding | 72.81M | 72.21M | 71.65M | 71.13M | 70.71M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |